Garlic for the common cold

Faculty of Medicine, Dentistry & Health Sciences, University of Western Australia, Crawley, WA, Australia, 6009.
Cochrane database of systematic reviews (Online) (Impact Factor: 5.94). 01/2009; DOI: 10.1002/14651858.CD006206.pub2
Source: PubMed

ABSTRACT Garlic is alleged to have antimicrobial and antiviral properties that relieve the common cold, among other beneficial effects. There is widespread usage of garlic supplements. The common cold is associated with significant morbidity and economic consequences. On average, children have six to eight colds per year, and adults have two to four.
To determine whether garlic (allium sativum) is effective for either the prevention or treatment of the common cold, when compared to placebo, no treatment or other treatments.
We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2009, issue 1), which includes the Acute Respiratory Infections Group Specialised Register; OLDMEDLINE (1950 to 1965); MEDLINE (January 1966 to March Week 3, 2009); EMBASE (1974 to March 2009); and AMED (1985 to March 2009).
Randomised controlled trials of common cold prevention and treatment comparing garlic with placebo, no treatment or standard treatment.
Two review authors independently reviewed and selected trials from searches, assessed and rated study quality, and extracted relevant data.
Of the five trials identified as potentially relevant from our searches, only one trial met the inclusion criteria. This trial randomly assigned 146 volunteer participants to either a garlic supplement (with 180 mg of allicin content) or a placebo (once daily) for 12 weeks. The trial reported 65 occurrences of the common cold in the placebo group compared with 24 in the garlic intervention group (P < 0.001). The number of days of illness was lower in the garlic group compared with the placebo group (111 versus 366). The number of days to recovery was similar in both groups (4.63 versus 5.63). Because only one trial met the inclusion criteria, limited conclusions can be drawn. The trial relied on self-reported episodes of the common cold, but was of reasonable quality in terms of randomisation and allocation concealment. Adverse effects included rash and odour.
There is insufficient clinical trial evidence regarding the effects of garlic in preventing or treating the common cold. A single trial suggested that garlic may prevent occurrences of the common cold, but more studies are needed to validate this finding. Claims of effectiveness appear to rely largely on poor quality evidence.

Download full-text


Available from: Marc Cohen, Jun 03, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Folk medicinal practitioners (Kavirajes) form the first tier of primary health care providers to most of the rural population of Bangladesh. Kavirajes use simple formulations of whole plant or plant parts from medicinal plants for treatment of various ailments. The medicinal plants used by the Kavirajes differ considerably in various areas of Bangladesh. The objective of the present study was to conduct a survey on medicinal plant usage by the Kavirajes of Daulatdia Ghat area in Kushtia district, Bangladesh. Interviews were conducted with the help of a semi-structured questionnaire and the guided field-walk method. Plant specimens as pointed out by the Kavirajes were collected and identified at the Bangladesh National Herbarium at Dhaka. It was observed that the Kavirajes of Daulatdia Ghat area used 49 plants distributed into 38 families for treatment of different ailments. The Fabaceae family contributed 4 plants followed by the Agavaceae family with 3 plants. Leaves and whole plants constituted the major parts used (24.6% each), followed by roots (22.8%) and fruits (7.0%). The Kavirajes treated a number of ailments or disorders. Gastrointestinal disorders were treated with 13 plants; skin disorders were treated with 9 plants; respiratory disorders were treated with 8 plants. Other disorders treated included leucorrhea (5 plants), sexual disorders (7 plants), diabetes (4 plants), rheumatism (5 plants), gall bladder stones (3 plants), fever (3 plants), urinary tract problems (3 plants), and pain (5 plants). The Kavirajes also treated debility, hepatic disorders, infections, poisoning, menstrual problems, heart diseases, typhoid, cuts and wounds, edema, measles, helminthiasis, piles, malaria, obesity, insanity, and ear and eye infections. Taken together, the medicinal plants used by the Kavirajes considerable potential for further scientific studies, which can lead to newer and more efficient drugs.
    American-Eurasian Journal of Sustainable Agriculture 01/2010; 4(2):219-229. · 2.54 Impact Factor
  • The Journal of allergy and clinical immunology 10/2010; 126(4):770-1. DOI:10.1016/j.jaci.2010.08.019 · 11.25 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Respiratory tract infections (RTIs) remain the commonest reason for acute consultations in primary care in resource-rich countries. Their spectrum and severity has changed from the time that antibiotics were discovered, largely from improvements in the socioeconomic determinants of health as well as vaccination. The benefits from antibiotic treatment for common RTIs have been shown to be largely overstated. Nevertheless, serious infections do occur. Currently, no clinical features or diagnostic test, alone or in combination, adequately determine diagnosis, aetiology, prognosis, or response to treatment. This narrative review focuses on emerging evidence aimed at helping clinicians reduce and manage uncertainty in treating RTIs. Consultation rate and prescribing rate trends are described, evidence of increasing rates of complications are discussed, and studies and the association with antibiotic prescribing are examined. Methods of improving diagnosis and identifying those patients who are at increased risk of complications from RTIs, using clinical scoring systems, biomarkers, and point of care tests are also discussed. The evidence for alternative management options for RTIs are summarised and the methods for changing public and clinicians' beliefs about antibiotics, including ways in which we can improve clinician-patient communication skills for management of RTIs, are described.
    British Journal of General Practice 12/2010; 60(581):e466-75. DOI:10.3399/bjgp10X544104 · 2.36 Impact Factor